The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents

Julia A Tree1, Helen Flick-Smith2, Michael J Elmore1

  • 1Biodefence and PreClinical Evaluation Group, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP5 3NU, UK.